gMG Connect
  • Saved

made a Post

3yr
Recap of the 2022 American Academy of Neurology Fall Conference

The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest advances in diagnosing and treating dementia, epilepsy, movement disorders, myasthenia gravis, and other brain disorders. The three-day hybrid AAN Fall Conference took place at Caesars Palace in Las Vegas from Oct. 28 to 30, 2022. The digital on-demand content will be available in the Online Learning Center from Nov. 14, 2022, until Aug. 1, 2023.

Click above for a wrap-up of all the conference highlights.

  • Saved

made a Post

3yr
Recap of the 2022 American Academy of Neurology Fall Conference

The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest advances in diagnosing and treating dementia, epilepsy, movement disorders, myasthenia gravis, and other brain disorders. The three-day hybrid AAN Fall Conference took place at Caesars Palace in Las Vegas from Oct. 28 to 30, 2022. The digital on-demand content will be available in the Online Learning Center from Nov. 14, 2022, until Aug. 1, 2023.

Click above for a wrap-up of all the conference highlights.

  • Saved

3yr
Impact of the COVID-19 pandemic on Patients with Myasthenia Gravis: A survey of the Myasthenia Gravis Foundation of America MG Patient Registry - PubMed

Impact of the COVID-19 pandemic on Patients with Myasthenia Gravis: A survey of the Myasthenia Gravis Foundation of America MG Patient Registry - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36324261/

COVID-19 affected MG patients increasingly through the early pandemic. While face-to-face contact with a COVID-19 infected individual was an obvious risk factor, MG patients who had more people in the...


Discussion: COVID-19 affected MG patients increasingly through the early pandemic. While face-to-face contact with a COVID-19 infected individual was an obvious risk factor, MG patients who had more people in the household and unstable disease were at elevated risk for COVID-19 infection.


  • Saved

3yr
Tailoring Two Chemometric Models for Determination of Three Neuromuscular Combined Medications and Application to Spiked Human Plasma

Tailoring Two Chemometric Models for Determination of Three Neuromuscular Combined Medications and Application to Spiked Human Plasma

Source : https://academic.oup.com/jaoac/advance-article-abstract/doi/10.1093/jaoacint/qsac139/6794206?redirectedFrom=fulltext&login=false

AbstractBackground. Prednisolone, 6-mercaptopurine and pyridostigmine bromide are co-administered together to treat a neuromuscular autoimmune disease called my

/>

Conclusions: The developed models succeeded to predict the proposed drugs in their tertiary combinations and spiked human plasma with satisfied precision, accuracy, and good greenness behavior.

  • Saved

3yr
The best and worst of times in therapy development for myasthenia gravis - PubMed

The best and worst of times in therapy development for myasthenia gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36321730/

Within the last 5 years the U.S. Federal Drug Administration (FDA) has approved complement and neonatal Fc receptor (FcRN)-inhibitors for treatment of generalized myasthenia gravis; and several other therapies are...


Relevance: The authors provide a summary of these discussions, but not a consensus opinion, and offer a series of recommendations to guide focused research in the most critical areas. We welcome ongoing discussion through comments on this publication.